Literature DB >> 25328468

Bilateral pulmonary embolism in an adolescent with sickle cell disease and a recent total hip arthroplasty: a case report and review of the literature.

Jeremy M Burnham1, Marlene Broussard2, Todd Milbrandt1.   

Abstract

Pulmonary embolism is a life-threatening but treatable condition. Factors such as hypercoagulability and recent lower extremity surgery are associated with a higher incidence of thrombus formation and pulmonary embolism. Patients with sickle cell disease have a baseline hypercoaguable state and are at a greater risk forming deep vein thrombosis and pulmonary embolism than the general population. This increased risk is rarely cited in the literature. We describe a sickle cell patient two-weeks status-post total hip arthroplasty who presented with bilateral pulmonary embolism complaining of chest and shoulder pain. We highlight the need to include pulmonary embolism in the differential diagnosis of all sickle cell patients complaining of chest pain.

Entities:  

Mesh:

Year:  2014        PMID: 25328468      PMCID: PMC4127743     

Source DB:  PubMed          Journal:  Iowa Orthop J        ISSN: 1541-5457


  17 in total

1.  Pulmonary embolism. A clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants.

Authors:  R E HERMANN; J H DAVIS; W D HOLDEN
Journal:  Am J Surg       Date:  1961-07       Impact factor: 2.565

2.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.

Authors:  D W BARRITT; S C JORDAN
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

3.  The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism.

Authors:  Marc A Rodger; Christopher N Bredeson; Gwynne Jones; Pasteur Rasuli; François Raymond; Anne Marie Clement; Alan Karovitch; Helene Brunette; Dimitri Makropoulos; Mark Reardon; Ian Stiell; Rama Nair; Philip S Wells
Journal:  Arch Intern Med       Date:  2006-01-23

Review 4.  Venous thromboembolic complications in children.

Authors:  M David; M Andrew
Journal:  J Pediatr       Date:  1993-09       Impact factor: 4.406

5.  Sickle cell trait and the risk of venous thromboembolism among blacks.

Authors:  Harland Austin; Nigel S Key; Jane M Benson; Cathy Lally; Nicole F Dowling; Carolyn Whitsett; W Craig Hooper
Journal:  Blood       Date:  2007-04-04       Impact factor: 22.113

6.  Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.

Authors:  Arne van Belle; Harry R Büller; Menno V Huisman; Peter M Huisman; Karin Kaasjager; Pieter W Kamphuisen; Mark H H Kramer; Marieke J H A Kruip; Johanna M Kwakkel-van Erp; Frank W G Leebeek; Mathilde Nijkeuter; Martin H Prins; Maaike Sohne; Lidwine W Tick
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

7.  Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease.

Authors:  Paul D Stein; Afzal Beemath; Frederick A Meyers; Elias Skaf; Ronald E Olson
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

8.  Total hip replacement in sickle cell disease.

Authors:  F Al-Mousawi; A Malki; A Al-Aradi; M Al-Bagali; A Al-Sadadi; M M Y Booz
Journal:  Int Orthop       Date:  2002-04-05       Impact factor: 3.075

9.  Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study.

Authors:  Young-Hoo Kim; S H Oh; J S Kim
Journal:  J Bone Joint Surg Br       Date:  2003-07

10.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

View more
  1 in total

1.  Incidence of sickle cell disease patients with pulmonary embolism admitted to the intensive care unit in Bahrain.

Authors:  Fatema H Mandeel; Hasan M Saeed; Ahmed H Alsadah; Sara A Ahmed; Redha A Alhammam
Journal:  Saudi Med J       Date:  2020-08       Impact factor: 1.484

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.